Xingxing Shelley Cheng, MD
Nephrology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cheng’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A129418 · Current
Licensed to practise in California · since 2014 · expires 2028-03-31 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$41,281
Medicare paid this office $41,281 for 164 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 43 | $14,520 | $126 |
| Long return visit (40+ min) | 35 | $8,912 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $7,363 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,455 | $117 |
| Return visit (30+ min) | 19 | $2,423 | $105 |
See all 6 services
| Long return visit (40+ min) | 43 | $14,520 | $126 |
| Long return visit (40+ min) | 35 | $8,912 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $7,363 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,455 | $117 |
| Return visit (30+ min) | 19 | $2,423 | $105 |
| Return visit (30+ min) | 13 | $1,539 | $85 |
Who their Medicare patients are
164 Original Medicare patients in 2024. Average age 61 · Under 65 48% · Women 38% · Also on Medicaid 56% · Health risk score 5.65. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 74% · Coronary heart disease 48% · Heart failure 44% · Atrial fibrillation 26% · Depression 22% · Dementia 16% · Cancer 15% · Stroke 15% · COPD 7%.
The office billed $165,405, Medicare allowed $53,200 and paid $41,281; for 372 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 164 | 372 | 61 | 5.65 | $165,405 | $41,281 |
| 2023 | 207 | 538 | 63 | 6.22 | $234,622 | $50,923 |
| 2022 | 133 | 277 | 61 | 5.44 | $132,703 | $28,114 |
| 2021 | 148 | 458 | 60 | 5.72 | $210,050 | $48,587 |
| 2020 | 167 | 540 | 59 | 6.34 | $173,529 | $40,614 |
| 2019 | 202 | 737 | 60 | 6.57 | $212,589 | $59,792 |
| 2018 | 110 | 193 | 61 | 5.32 | $59,637 | $17,030 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Long return visit (40+ min) | 63 | $18,417 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $15,024 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,501 | $95 |
| Return visit (30+ min) | 31 | $3,342 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,228 | $120 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,759 | $160 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,210 | $76 |
2022: 5 services
| Long return visit (40+ min) | 56 | $15,291 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $4,200 | $65 |
| Return visit (30+ min) | 20 | $2,086 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,003 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $1,871 | $94 |
2021: 6 services
| Long return visit (40+ min) | 67 | $27,286 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $5,842 | $66 |
| Return visit (30+ min) | 37 | $5,117 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $3,055 | $95 |
| Hemodialysis procedure with physician evaluation | 11 | $810 | $67 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $389 | $35 |
2020: 6 services
| Long return visit (40+ min) | 50 | $12,534 | $99 |
| Return visit (30+ min) | 55 | $8,212 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $7,288 | $67 |
| Short return visit (20+ min) | 36 | $2,813 | $46 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,574 | $93 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $943 | $36 |
2019: 10 services
| Long return visit (40+ min) | 62 | $20,444 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 83 | $10,878 | $64 |
| Return visit (30+ min) | 45 | $7,846 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $6,869 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,798 | $181 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,805 | $122 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $1,435 | $33 |
| Hemodialysis procedure with physician evaluation | 18 | $1,243 | $65 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $985 | $90 |
| Short return visit (20+ min) | 11 | $869 | $46 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $5,524 | $94 |
| Long return visit (40+ min) | 32 | $3,691 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,746 | $65 |
| Return visit (30+ min) | 21 | $1,413 | $67 |
Medicaid work
$1,904 in 2024
Medicaid paid $1,904 for 90 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 68 | $1,202 |
| Long return visit (40+ min) | 22 | $701 |
| 2024 | 90 | 2 | 22 | $1,904 |
| 2023 | 261 | 2 | 21 | $6,913 |
| 2022 | 79 | 2 | 15 | $1,643 |
| 2021 | 122 | 2 | 15 | $2,687 |
| 2020 | 135 | 2 | 23 | $2,791 |
| 2019 | 79 | 2 | 19 | $2,312 |
| 2018 | 53 | 1 | 15 | $1,296 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 211 | $5,332 |
| Long return visit (40+ min) | 50 | $1,581 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 39 | $915 |
| Long return visit (40+ min) | 40 | $728 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 93 | $2,307 |
| Long return visit (40+ min) | 29 | $380 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 89 | $2,019 |
| Return visit (30+ min) | 46 | $773 |
2019
| Long return visit (40+ min) | 52 | $1,628 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 27 | $684 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 53 | $1,296 |
Drugs they prescribed that Part D paid
$49,527
Pharmacies billed $49,527 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
357 generic and fewer than 11 brand-name prescriptions · $49,527 in drug cost · 23 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Valganciclovir | 18 | $2,481 | $138 |
| Tacrolimus | 40 | $2,465 | $62 |
| Mycophenolate Mofetil | 18 | $1,492 | $83 |
| Methenamine Hippurate | 14 | $1,050 | $75 |
| Prednisone | 107 | $418 | $4 |
See all 11 drugs
| Valganciclovir | 18 | $2,481 | $138 |
| Tacrolimus | 40 | $2,465 | $62 |
| Mycophenolate Mofetil | 18 | $1,492 | $83 |
| Methenamine Hippurate | 14 | $1,050 | $75 |
| Prednisone | 107 | $418 | $4 |
| Levothyroxine | 12 | $120 | $10 |
| Carvedilol | 11 | $88 | $8 |
| Tamsulosin | 14 | $75 | $5 |
| Atorvastatin | 16 | $70 | $4 |
| Losartan | 12 | $69 | $6 |
| Amlodipine Besylate | 14 | $60 | $4 |
Year by year
| 2024 | 395 | 64 | None | None | $49,527 |
| 2023 | 482 | 65 | None | None | $81,341 |
| 2022 | 535 | 63 | None | None | $53,260 |
| 2021 | 507 | 69 | 0% (0) | 6% | $58,227 |
| 2020 | 676 | 65 | None | None | $165,297 |
| 2019 | 374 | 53 | None | 15% | $154,631 |
| 2018 | 43 | 15 | None | None | $17,102 |
| 2016 | 55 | 15 | 0% (0) | 24% | $1,267 |
| 2015 | 25 | None | 0% (0) | None | $3,164 |
| 2014 | 231 | 26 | None | 13% | $21,841 |
| 2013 | 347 | 42 | None | 24% | $29,840 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Atovaquone | 23 | $27,434 | $1,193 |
| Lokelma | 11 | $13,081 | $1,189 |
| Tacrolimus | 50 | $12,322 | $246 |
| Valganciclovir | 11 | $2,244 | $204 |
| Mycophenolate Mofetil | 26 | $2,233 | $86 |
| Losartan | 14 | $578 | $41 |
| Prednisone | 95 | $575 | $6 |
| Tamsulosin | 21 | $318 | $15 |
| Amlodipine Besylate | 23 | $248 | $11 |
| Atorvastatin | 19 | $156 | $8 |
| Carvedilol | 13 | $146 | $11 |
| Pantoprazole | 24 | $109 | $5 |
| Sulfamethoxazole-Trimethoprim | 22 | $62 | $3 |
| Furosemide | 11 | $51 | $5 |
2022: 12 drugs
| Tacrolimus | 62 | $19,360 | $312 |
| Mycophenolate Mofetil | 28 | $2,515 | $90 |
| Sulfamethoxazole-Trimethoprim | 28 | $511 | $18 |
| Prednisone | 88 | $441 | $5 |
| Warfarin | 12 | $293 | $24 |
| Tamsulosin | 18 | $223 | $12 |
| Atorvastatin | 41 | $195 | $5 |
| Amlodipine Besylate | 31 | $191 | $6 |
| Lisinopril | 19 | $130 | $7 |
| Pantoprazole | 19 | $128 | $7 |
| Chlorthalidone | 11 | $127 | $12 |
| Carvedilol | 21 | $79 | $4 |
2021: 12 drugs
| Tacrolimus | 43 | $12,729 | $296 |
| Comfort Ez Pen Needle | 14 | $1,196 | $85 |
| Mycophenolate Mofetil | 11 | $851 | $77 |
| Prednisone | 100 | $550 | $6 |
| Chlorthalidone | 11 | $431 | $39 |
| Lisinopril | 45 | $298 | $7 |
| Fludrocortisone Acetate | 25 | $245 | $10 |
| Tamsulosin | 20 | $234 | $12 |
| Sulfamethoxazole-Trimethoprim | 19 | $164 | $9 |
| Amlodipine Besylate | 14 | $143 | $10 |
| Atorvastatin | 11 | $103 | $9 |
| Carvedilol | 18 | $99 | $6 |
2020: 16 drugs
| Cinacalcet | 36 | $67,523 | $1,876 |
| Tacrolimus | 56 | $12,116 | $216 |
| Mycophenolate Mofetil | 33 | $1,534 | $46 |
| Chlorthalidone | 15 | $985 | $66 |
| Methylprednisolone | 18 | $853 | $47 |
| Valganciclovir | 11 | $792 | $72 |
| Fludrocortisone Acetate | 33 | $584 | $18 |
| Prednisone | 97 | $539 | $6 |
| Tamsulosin | 31 | $511 | $16 |
| Furosemide | 30 | $211 | $7 |
| Atorvastatin | 31 | $178 | $6 |
| Gabapentin | 13 | $158 | $12 |
| Sulfamethoxazole-Trimethoprim | 33 | $81 | $2 |
| Carvedilol | 17 | $57 | $3 |
| Glipizide | 12 | $40 | $3 |
| Lisinopril | 18 | $37 | $2 |
2019: 13 drugs
| Cinacalcet | 43 | $80,367 | $1,869 |
| Sensipar | 18 | $45,073 | $2,504 |
| Tacrolimus | 11 | $1,537 | $140 |
| Chlorthalidone | 15 | $719 | $48 |
| Ultra-Fine Short Pen Needle | 12 | $623 | $52 |
| Prednisone | 37 | $265 | $7 |
| Atorvastatin | 19 | $234 | $12 |
| Methylprednisolone | 13 | $226 | $17 |
| Fludrocortisone Acetate | 13 | $175 | $13 |
| Tamsulosin | 12 | $160 | $13 |
| Furosemide | 22 | $117 | $5 |
| Losartan | 13 | $50 | $4 |
| Sulfamethoxazole-Trimethoprim | 12 | $43 | $4 |
2016: 1 drug
| Furosemide | 12 | $73 | $6 |
2014: 6 drugs
| Metoprolol | 11 | $1,320 | $120 |
| Tamsulosin | 16 | $253 | $16 |
| Allopurinol | 20 | $173 | $9 |
| Lisinopril | 24 | $155 | $6 |
| Hydrochlorothiazide | 21 | $89 | $4 |
| Simvastatin | 12 | $88 | $7 |
2013: 9 drugs
| Vesicare | 12 | $2,427 | $202 |
| Lovaza | 16 | $2,329 | $146 |
| Metoprolol | 26 | $1,911 | $74 |
| Lisinopril | 22 | $228 | $10 |
| Allopurinol | 33 | $226 | $7 |
| Simvastatin | 14 | $172 | $12 |
| Tamsulosin | 13 | $160 | $12 |
| Omeprazole | 13 | $140 | $11 |
| Hydrochlorothiazide | 16 | $92 | $6 |
Money from drug and device companies
$3,600 in 2024
| 2024 | 1 | 2 | $3,600 | $3,600 |
| 2021 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mallinckrodt Hospital Products | Terlivaz | $3,600 | 2 payments
|
See all 2 published payments
| Mallinckrodt Hospital Products | Paid to speak or teach · 2024-04-04 | Terlivaz | $2,250 |
| Mallinckrodt Hospital Products | Paid to speak or teach · 2024-02-08 | Terlivaz | $1,350 |
See earlier years (2021)
2021: $125
| Ablative Solutions | None | $125 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1558656231
- Licence
- CA A129418, MA L-247888California A129418: Current · expires 2028-03-31
- Trained
- Washington University School of Medicine, 2011
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-06-10
- NPI last updated
- 2024-04-18
- NPI record certified
- 2024-04-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: Massachusetts General Hospital, Boston, MA, 02114